August 16, 2024 11:17 AM EDTUpdated 01:41 PM
Deals
Outsourcing

Avan­tor sells off CRO for $650M to pri­vate eq­ui­ty firm

Katherine Lewin

News Reporter

Au­dax Pri­vate Eq­ui­ty is buy­ing Avan­tor’s CRO busi­ness for about $650 mil­lion.

The deal, an­nounced Fri­day, is for Avan­tor’s clin­i­cal ser­vices …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Scor­pi­on de­tails ear­ly da­ta on tar­get­ed breast can­cer drug as it seeks to chal­lenge No­var­tis, Roche

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

Up­dat­ed: Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer, but da­ta caveats damp­en ex­cite­ment

Post-Hoc: Big promis­es built Mod­er­na. They might al­so be its un­do­ing

A service from the Financial Times